Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kodiak Sciences
Kodiak Sciences
Kodiak Sciences dosing subjects in Phase III trial of diabetic retinopathy drug
Clinical Trials Arena
Tue, 05/14/24 - 11:27 am
Kodiak Sciences
clinical trials
tarcocimab tedromer
diabetic retinopathy
Kodiak CMO Steps Down After Phase III Flops for Eye Therapy
BioSpace
Fri, 08/18/23 - 10:22 am
Kodiak Sciences
clinical trials
tarcocimab tedromer
3 Biotech Stocks Poised to Beat Q2 Earnings Estimates
Yahoo/Zacks.com
Mon, 08/14/23 - 11:15 am
earnings
Legend Biotech
Kodiak Sciences
Galera Therapeutics
Kodiak Sciences Scraps Late-Stage Vision Loss Biologic
BioSpace
Mon, 07/24/23 - 09:37 pm
Kodiak Sciences
diabetic macular edema
biologics
tarcocimab tedromer
Kodiak Sciences begins subject treatment in DME therapy trial
Clinical Trials Arena
Tue, 04/4/23 - 10:14 am
Kodiak Sciences
clinical trials
diabetic macular edema
KSI-501
Kodiak matches Regeneron’s Eylea in macular edema phase 3, lighting Beacon of hope after flop
Fierce Biotech
Tue, 08/9/22 - 06:34 am
Kodiak Sciences
Regeneron
Bayer
Eylea
macular edema
clinical trials
tarcocimab
Kodiak's Eylea rival hits 'major disappointment' with failure in first of 6 phase 3 studies
Fierce Biotech
Wed, 02/23/22 - 09:28 pm
Kodiak Sciences
KSI-301
Eylea
Bayer
Regeneron
Kodiak turns down $125M payment from Baker Bros. deal, slashes royalty cap by 55%
Endpoints
Fri, 07/23/21 - 10:58 am
Kodiak Sciences
Baker Brothers
funding
The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus
Yahoo/Benzinga
Mon, 02/3/20 - 10:37 am
earnings
Forty Seven
Jounce Therapeutics
Catalyst Biosciences
Kodiak Sciences
Adverum Biotechnologies
IPOs
Beam Therapeutics
JP Morgan Preview: Small, Medium and Large, with a Lot of M&A Speculation
BioSpace
Mon, 01/13/20 - 11:08 am
JPMHC 2020
M&A
Exelixis
Intercept Pharmaceuticals
Avidity Biosciences
Theravance
Moderna Therapeutics
Kodiak Sciences
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Sun, 09/15/19 - 10:05 pm
Merck
Pifeltro
FDA
Delstrigo
Novo Nordisk
oral semaglutide
Kodiak Sciences
MeiraGTx Holdings
IPOs
Exagen
IGM Biosciences
Arrowhead Pharmaceuticals
Lexicon Pharmaceuticals
Bluebird Bio
vTv Therapeutics
3 Biotech Stocks That Soared Last Week
Motley Fool
Sun, 09/15/19 - 09:51 pm
Acadia Pharmaceuticals
Nuplazid
Mesoblast
Grunenthal
MPC-06-ID
Kodiak Sciences
age-related macular degeneration
Top 5 Biotech Companies to Emerge From Bay Area Incubators
BioSpace
Wed, 02/27/19 - 07:25 pm
incubators
Bay Area
Gingko Bioworks
Kodiak Sciences
Mission Bio
uBiome
A Record Year: A Look at the Biotech IPOs for Q4 2018
BioSpace
Fri, 12/28/18 - 12:57 pm
IPOs
biotech
Moderna Therapeutics
Allogene
Rubius Therapeutics
Kodiak Sciences
Guardant Health
SI Bone
With anti-VEGF challenger in clinic, Kodiak files for IPO
BioCentury
Mon, 09/10/18 - 12:19 am
Kodiak Sciences
anti-VEGF
IPOs
Two more Peninsula IPOs tell the story of biotech's investment boom
Bizjournals.com
Sat, 09/8/18 - 11:43 pm
IPOs
Guardant Health
Kodiak Sciences